Xeris Biopharma Holdings (XERS) Intangibles (2021 - 2026)
Xeris Biopharma Holdings (XERS) reported Intangibles of $82.66 million for Q2 2026, down 11.6% from $93.5 million a year earlier and down 3.2% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings posted Intangibles of $88.08 million, down 11.0% from FY2024.
- Intangibles has declined for four consecutive years, with a four-year compound annual growth rate of -9.5% (FY2021 to FY2025).
- By year, Intangibles came in at $98.92 million in FY2024 (-9.9%), $109.76 million in FY2023 (-9.0%), $120.61 million in FY2022 (-8.2%) and $131.45 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Intangibles in data going back to Q4 2021.
- Year over year, Intangibles has now declined in each of the last 15 quarters, with an average decline of 10.6% over the last eight quarters.
- Over the past five years, the year-over-year decline in Intangibles ranged from 8.2% (Q4 2022) to 11.6% (Q2 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at $85.37 million (Q1 2026), $88.08 million (Q4 2025) and $90.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Xeris Biopharma Holdings | 1.66 Bn | 1.22 Bn | 79.59 Mn | 82.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82.66 Mn |
| Mar 31, 2026 | 85.37 Mn |
| Dec 31, 2025 | 88.08 Mn |
| Sep 30, 2025 | 90.79 Mn |
| Jun 30, 2025 | 93.50 Mn |
| Mar 31, 2025 | 96.21 Mn |
| Dec 31, 2024 | 98.92 Mn |
| Sep 30, 2024 | 101.63 Mn |
| Jun 30, 2024 | 104.34 Mn |
| Mar 31, 2024 | 107.05 Mn |
| Dec 31, 2023 | 109.76 Mn |
| Sep 30, 2023 | 112.48 Mn |
| Jun 30, 2023 | 115.19 Mn |
| Mar 31, 2023 | 117.90 Mn |
| Dec 31, 2022 | 120.61 Mn |
| Sep 30, 2022 | 123.32 Mn |
| Jun 30, 2022 | 126.03 Mn |
| Mar 31, 2022 | 128.74 Mn |
| Dec 31, 2021 | 131.45 Mn |
API Access
Xeris Biopharma Holdings Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();